BDBM351241 US9796700, Compound I-352
SMILES: CCC(=O)Nc1cc(C)ccc1Nc1nc(Nc2cc(OC)ncc2C)ncc1C(F)(F)F
InChI Key: InChIKey=WHUUZGGQZJCYSE-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MAP kinase ERK1 (Homo sapiens (Human)) | BDBM351241![]() (US9796700, Compound I-352) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene CAR LLC US Patent | Assay Description The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ... | US Patent US9796700 (2017) BindingDB Entry DOI: 10.7270/Q2J38VQD | |||||||||||
More data for this Ligand-Target Pair |